United States · FDA National Drug Code directory
Nicotine Mini
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 57237-321_02faa0ad-b311-4bfa-9e0f-b085939d7063
- Product NDC
- 57237-321
- Form
- LOZENGE
- Composition / generic term
- nicotine polacrilex
- Labeler
- Rising Pharma Holdings, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230810
- Source listing expiry
- 20261231
Source-listed ingredients
- NICOTINE — 4 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, PLASTIC in 1 BOX (57237-321-42) / 24 LOZENGE in 1 BOTTLE, PLASTIC · 57237-321-42
- 3 BOTTLE, PLASTIC in 1 BOX (57237-321-72) / 24 LOZENGE in 1 BOTTLE, PLASTIC · 57237-321-72
- 3 BOTTLE, PLASTIC in 1 BOX (57237-321-81) / 27 LOZENGE in 1 BOTTLE, PLASTIC (57237-321-27) · 57237-321-81
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →